A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

NCT00394771 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

567

Enrollment

INDUSTRY

Sponsor class

Conditions

Breakthrough Bleeding

Interventions

DRUG: DR-1031
DRUG: Seasonale®
DRUG: Portia®

Sponsor

Duramed Research